Product not found!

Well, I must apologize - I thought surely you were scamming me. But, all of a sudden, my mailbox overflows. I received one order on Thursday, 8 June, and then another on Saturday, 10 June. Almost 1 month from our first effort, but the postal service must be the culprits. With this double supply, you are now going to have to send me a couple of women, so the meds don't go to waste. How can we make this right? What would you like me to do? Thanks. I hope only good karma comes to you. - Curt

Exciting New Research Results Reported at the Recent European Society of ... - MarketWatch (press release)
Exciting New Research Results Reported at the Recent European Society of .
Generics in Cardiovascular Diseases Market to 2018 - Loss of Lipitor Market ... - Sacramento Bee
Generics in Cardiovascular Diseases Market to 2018 - Loss of Lipitor Market .
Loopholes in pharma pricing policy - Hindu Business Line
Hindu Business LineLoopholes in pharma pricing policyHindu Business LineSimilarly in the class of angiotensin II receptor antagonists (also used in high blood pressure), we have losartan potassium in the NLEM 2011 list but not candesartan, irbesartan, telmisartan, valsartan and olmesartan.
Progress report on the first sub-Saharan trial of newer versus older ... - 7thSpace Interactive (press release)
Progress report on the first sub-Saharan trial of newer versus older .
Novartis: A Sleeper Or A Headache? - Seeking Alpha
Novartis: A Sleeper Or A Headache?Seeking AlphaThis last quarter, Novartis missed the street estimates mainly because of looming patent expiration of some of their best-selling prescription drugs, most notably Diovan (valsartan).

product valsartan is not found!

Our billing is certified by: